Related Experiment Video
Updated: Jul 25, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Cryptococcal meningitis in pediatric systemic lupus erythematosus
1Department of Pediatrics, Veterans General Hospital, Taichung, No. 160, Sec 3, Chung-kang Rd., Taichung 407, Taiwan.
Insights
Cryptococcal meningitis is a rare but serious complication in patients with systemic lupus erythematosus (SLE). Early diagnosis and treatment with antifungal medications can lead to a positive outcome, preventing long-term neurological issues.
Area of Science:
- Infectious Diseases
- Rheumatology
- Neurology
Background:
- Systemic lupus erythematosus (SLE) is an autoimmune disease that can predispose patients to opportunistic infections.
- Cryptococcal meningitis, caused by Cryptococcus neoformans, is a rare but life-threatening complication in immunocompromised individuals, including those with SLE.
Observation:
- A 13-year-old female with SLE on high-dose prednisolone presented with fever, vomiting, and headache.
- Cerebrospinal fluid (CSF) analysis revealed a cryptococcal antigen titer of 1:128 and culture-positive Cryptococcus neoformans.
Findings:
- The patient was treated with amphotericin B deoxycholate and fluconazole for six weeks.
- Suppressive fluconazole therapy was continued for 34 months, resulting in no relapse or neurological sequelae during a 20-month follow-up period.
Implications:
- This case highlights the importance of prompt diagnosis and aggressive antifungal treatment for cryptococcal meningitis in SLE patients.
- Effective management can significantly improve patient prognosis and prevent long-term neurological complications.
Abstract:
Cryptococcal meningitis is an uncommon but often fatal complication of systemic lupus erythematosus (SLE). We report on a 13-year-old girl with SLE using high-dose prednisolone for several months, presented to us with low grade fever, intermittent vomiting and headache. Physical examination, including papilloedema and meningeal irritation, was unremarkable. Serum and cerebrospinal fluid (CSF) cryptococcal antigen titer was 1: 128 by latex agglutination method. CSF culture yielded Cryptococcus neoformans. We used amphotericin B deoxycholate (a cumulative dose of 1.95 gm) and fluconazole (200 mg day-1) for 6 weeks. Clinical response was good. Then, we continued fluconazole 200 mg per qd as suppressive therapy for thirty-four months. There were no neurological sequelae or relapse after 20-month follow-up. Timely diagnosis and effective antifungal therapy could improve the prognosis of cryptococcal meningitis in SLE patients.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Fungal Phylum Microsporidia
Rocky Mountain Spotted Fever
Cryptococcal Meningitis
Encephalitis l: Introduction

